InvestorsHub Logo
Followers 3156
Posts 962180
Boards Moderated 183
Alias Born 09/04/2000

Re: mick post# 2963

Sunday, 04/18/2021 1:34:22 PM

Sunday, April 18, 2021 1:34:22 PM

Post# of 4867
GILD Investor Relations
http://investors.gilead.com/events?c=69964&p=irol-calendar
Viral Disease Pipeline Phase 1 Phase 2 Phase 3 NDA/BLA/MAA HIV Biktarvy HIV treatment pediatric1 Capsid inhibitor (GS-6207)
HIV HTE HIV treatment naïve Vesatolimod (GS-9620, TLR-7 agonist) HIV cure Elipovimab (GS-9722, bNAb)
HIV cure HBV Selgantolimod
(GS-9688,TLR-8 agonist) HBV cure PD-L1 inhibitor (GS-4224) HBV cure 1 Biktarvy HIV treatment pediatric label extension.
2 Registrational for heavily treatment-experienced (HTE) patients.

http://investors.gilead.com/stock-information/stock-quote-chart
http://investors.gilead.com/stock-information/historical-price-lookup
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News